基本説明
Highlights recent advances and emerging technologies in the pathology of lung cancer and their relationship to clinical care.
Full Description
Advances in Surgical PathologySurgical Pathology series, features chapters on current and impending changes in the field of lung cancer that directly affect pathologists. This includes the 2004 updates of the WHO Classification of Tumors of the Lung; the ongoing new classification of neuroendocrine carcinomas of the lung by the International Association for the Study of Lung Cancer; the ongoing revision of the pathologic and clinical staging of lung cancer by the AJCC; molecular diagnostics in the diagnosis of lung cancer; the role of the pathologist in the new molecular targeted therapies for lung cancer; and the new use of image-guided, multimodality theranostics for the diagnosis and treatment of lung cancer. Other current topics discussed include new understanding of the premalignant and preinvasive lesions and the controversies and revisions of the diagnosis of bronchioloalveolar carcinoma.
Contents
Section 1. Overview (include immunohistochemistry)Chapter 1: IntroductionChapter 2: Overview of Lung CancerSection 2. HistopathologyChapter 3: AdenocarcinomaChapter 4: Bronchioloalveolar CarcinomasChapter 5: Changing Concepts of Bronchioloalveolar Carcinoma and AdenocarcinomaChapter 6: Squamous Cell CarcinomaChapter 7: Adenosquamous CarcinomaChapter 8: Large Cell CarcinomaChapter 9: Small Cell CarcinomaChapter 10: Carcinoid TumorChapter 11: Atypical CarcinoidChapter 12: Update on Classification of Neuroendocrine CarcinomasChapter 13: Sarcomatoid (Sarcomatous) CarcinomaChapter 14: Giant Cell CarcinomaChapter 15: Pulmonary BlastomaChapter 16: Salivary Gland-like CarcinomasChapter 17: Metastatic CarcinomaSection 3. ImagingChapter 18: Correlation of Imaging with Histopathology of Lung CancerChapter 19: New Imaging Techniques for the Diagnosis and Staging of Lung CancerChapter 20: Multimodality Theranostics and Molecular Radiology in the Diagnosis and Treatment of Lung CancerSection 4. Molecular PathologyChapter 21: Molecular Diagnostics of Lung CancerChapter 22: Molecular Targeted Therapy of Lung CancerChapter 23: Molecular Prognostic Markers of Lung CancerSection 5. StagingChapter 24: Problems in the Staging of Lung CancerChapter 25: New Staging System for Lung CancerSection 6. Preneoplastic and Preinvasive LesionsChapter 26: Squamous cell carcinoma precursorsChapter 27: Atypical adenomatous hyperplasiaChapter 28: Diffuse idiopathic neuroendocrine hyperplasiaChapter 29: Other Precursors of Pulmonary Carcinomas
